BiondVax Pharmaceuticals News

BVXVDelisted Stock  USD 1.35  0.03  2.17%   
Slightly above 61% of BiondVax Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in BiondVax Pharmaceuticals suggests that many traders are alarmed regarding BiondVax Pharmaceuticals' prospects. BiondVax Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, BiondVax Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
Vaccine Market Share and Size Recent Growing Trend 2030 - Benzinga
Google News at Macroaxis
over a year ago at news.google.com         
Form 424B3 Scinai Immunotherapeutic - StreetInsider.com
Google News at Macroaxis
over a year ago at globenewswire.com         
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Dev...
Macroaxis News: globenewswire.com
over a year ago at thelincolnianonline.com         
BiondVax Pharmaceuticals Receives New Coverage from Analysts at StockNews.com
news
over a year ago at news.google.com         
Global Influenza Vaccines Research Analysis Report 2023 A Potential 10.9 Billion market by 2030 - Ex...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
BiondVax Pharmaceuticals Shares Cross Below Fifty Day Moving Average of 1.38
news
over a year ago at benzinga.com         
BiondVax Reports Second Quarter Financial Results and Provides Business Update
benzinga news
over a year ago at seekingalpha.com         
Biondvax Pharmaceuticals reports Q2 results
seekingalpha News
over a year ago at news.google.com         
Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
BioMedNewsBreaks BiondVax Pharmaceuticals Ltd.s NASDAQ ... - Financial Content
Google News at Macroaxis
over a year ago at news.google.com         
PainReform regains compliance with Nasdaqs minimum bid price ... - Seeking Alpha
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Short Interest in BiondVax Pharmaceuticals Ltd. Declines By 80.9
news
over a year ago at finance.yahoo.com         
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Amir Reichman, CEO of BiondVax Pharm...
Yahoo News
over a year ago at news.google.com         
BioMedNewsBreaks MoonLake Immunotherapeutics NASDAQ ... - StreetInsider.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about BiondVax Pharmaceuticals that are available to investors today. That information is available publicly through BiondVax media outlets and privately through word of mouth or via BiondVax internal channels. However, regardless of the origin, that massive amount of BiondVax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BiondVax Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BiondVax Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BiondVax Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BiondVax Pharmaceuticals alpha.

BiondVax Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Healthcare Stocks Moving Up and Down Wednesday ENVB, ZURA, KMDA, RETA, BHG, CWBR, PTCT, ELEV - InvestorsObserver
05/24/2023
2
StockNews.com Initiates Coverage on BiondVax Pharmaceuticals
05/31/2023
3
BiondVax Pharmaceuticals Receives New Coverage from Analysts at StockNews.com
06/08/2023
4
Short Interest in BiondVax Pharmaceuticals Ltd. Declines By 80.9
07/14/2023
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in BiondVax Stock

If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges